Elucidation of clearance mechanism of TP0463518, a novel hypoxia-inducible factor prolyl hydroxylase inhibitor: does a species difference in excretion routes exist between humans and animals?

References

• Basit A, Radi Z, Vaidya VS, Karasu M, Prasad B. 2019. Kidney cortical transporter expression across species using quantitative proteomics. Drug Metab Dispos. 47(8):802–808.
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. 1993. Physiological parameters in laboratory animals and humans. Pharm Res. 10(7):1093–1095.
   PubMed Web of Science ®Google Scholar
• De Bruyn T, Ufuk A, Cantrill C, Kosa RE, Bi YA, Niosi M, Modi S, Rodrigues AD, Tremaine LM, Varma MVS, et al. 2018. Predicting human clearance of organic anion transporting polypeptide substrates using cynomolgus monkey: in vitro–in vivo scaling of hepatic uptake clearance. Drug Metab Dispos. 46(7):989–1000.
   PubMed Web of Science ®Google Scholar
• El-Kattan AF, Varma MV, Steyn SJ, Scott DO, Maurer TS, Bergman A. 2016. Projecting ADME behavior and drug–drug interactions in early discovery and development: application of the extended clearance classification system. Pharm Res. 33(12):3021–3030.
   PubMed Web of Science ®Google Scholar
• Ghibellini G, Vasist LS, Leslie EM, Heizer WD, Kowalsky RJ, Calvo BF, Brouwer KL. 2007. In vitro–in vivo correlation of hepatobiliary drug clearance in humans. Clin Pharmacol Ther. 81(3):406–413.
   PubMed Web of Science ®Google Scholar
• Hamada M, Takayama T, Shibata T, Hiratate A, Takahashi M, Yashiro M, Takayama N, Okumura-Kitajima L, Koretsune H, Kajiyama H, et al. 2018. Discovery of novel 2-[(4-hydroxy-6-oxo-2,3-dihydro-1H-pyridine-5-carbonyl)amino]acetic acid derivatives as HIF prolyl hydroxylase inhibitors for treatment of renal anemia. Bioorg Med Chem Lett. 28(10):1725–1730.
   PubMed Web of Science ®Google Scholar
• Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS, Kaelin WG Jr. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 292(5516):464–468.
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ, et al. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292(5516):468–472.
   PubMed Web of Science ®Google Scholar
• Kassebaum NJ, Jasrasaria R, Naghavi M, Wulf SK, Johns N, Lozano R, Regan M, Weatherall D, Chou DP, Eisele TP, et al. 2014. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 123(5):615–624.
   PubMed Web of Science ®Google Scholar
• Kato S, Ochiai N, Takano H, Io F, Takayama N, Koretsune H, Kunioka EI, Uchida S, Yamamoto K. 2019. TP0463518, a novel prolyl hydroxylase inhibitor, specifically induces erythropoietin production in the Liver. J Pharmacol Exp Ther. 371(3):675–683.
   PubMed Web of Science ®Google Scholar
• Kato S, Takayama N, Takano H, Koretsune H, Koizumi C, Kunioka EI, Uchida S, Takahashi T, Yamamoto K. 2018. TP0463518, a novel inhibitor for hypoxia-inducible factor prolyl hydroxylases, increases erythropoietin in rodents and monkeys with a good pharmacokinetics-pharmacodynamics correlation. Eur J Pharmacol. 838:138–144.
   PubMed Web of Science ®Google Scholar
• Kato Y, Kuge K, Kusuhara H, Meier PJ, Sugiyama Y. 2002. Gender difference in the urinary excretion of organic anions in rats. J Pharmacol Exp Ther. 302(2):483–489.
   PubMed Web of Science ®Google Scholar
• Kimoto E, Bi YA, Kosa RE, Tremaine LM, Varma MVS. 2017. Hepatobiliary clearance prediction: species scaling from monkey, dog, and rat, and in vitro-in vivo extrapolation of sandwich-cultured human hepatocytes using 17 drugs. J Pharm Sci. 106(9):2795–2804.
   PubMed Web of Science ®Google Scholar
• McGonigle RJ, Wallin JD, Shadduck RK, Fisher JW. 1984. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 25(2):437–444.
   PubMed Web of Science ®Google Scholar
• Moldéus P, Högberg J, Orrenius S. 1978. Isolation and use of liver cells. Methods Enzymol. 52:60–71.
   PubMedGoogle Scholar
• Mole DR, Blancher C, Copley RR, Pollard PJ, Gleadle JM, Ragoussis J, Ratcliffe PJ. 2009. Genome-wide association of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha DNA binding with expression profiling of hypoxia-inducible transcripts. J Biol Chem. 284(25):16767–16775.
   PubMed Web of Science ®Google Scholar
• Rabinowitz MH. 2013. Inhibition of hypoxia-inducible factor prolyl hydroxylase domain oxygen sensors: tricking the body into mounting orchestrated survival and repair responses. J Med Chem. 56(23):9369–9402.
   PubMed Web of Science ®Google Scholar
• Seglen PO. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29–83.
   PubMedGoogle Scholar
• Semenza GL. 2011. Oxygen sensing, homeostasis, and disease. N Engl J Med. 365(6):537–547.
   PubMed Web of Science ®Google Scholar
• Shen H, Su H, Liu T, Yao M, Mintier G, Li L, Fancher RM, Iyer R, Marathe P, Lai Y, Rodrigues AD. 2015. Evaluation of rosuvastatin as an organic anion transporting polypeptide (OATP) probe substrate: in vitro transport and in vivo disposition in cynomolgus monkeys. J Pharmacol Exp Ther. 353(2):380–391.
   PubMed Web of Science ®Google Scholar
• Shen H, Yang Z, Mintier G, Han YH, Chen C, Balimane P, Jemal M, Zhao W, Zhang R, Kallipatti S, et al. 2013. Cynomolgus monkey as a potential model to assess drug interactions involving hepatic organic anion transporting polypeptides: in vitro, in vivo, and in vitro-to-in vivo extrapolation. J Pharmacol Exp Ther. 344(3):673–685.
   PubMed Web of Science ®Google Scholar
• Shinfuku A, Shimazaki T, Fujiwara M, Sato F, Watase H, Numazaki T, Kawakita Y, Mutoh M, Yamasaki H, Takayama N, et al. 2018. Novel compound induces erythropoietin secretion through liver effects in chronic kidney disease patients and healthy volunteers. Am J Nephrol. 48(3):157–164.
   PubMed Web of Science ®Google Scholar
• Souza E, Cho KH, Harris ST, Flindt NR, Watt RK, Pai AB. 2020. Hypoxia-inducible factor prolyl hydroxylase inhibitors: a paradigm shift for treatment of anemia in chronic kidney disease? Expert Opin Investig Drugs. 29(8):831–844.
   PubMed Web of Science ®Google Scholar
• Svoboda M, Riha J, Wlcek K, Jaeger W, Thalhammer T. 2011. Organic anion transporting polypeptides (OATPs): regulation of expression and function. Curr Drug Metab. 12(2):139–153.
   PubMed Web of Science ®Google Scholar
• Wang L, Prasad B, Salphati L, Chu X, Gupta A, Hop CE, Evers R, Unadkat JD. 2015. Interspecies variability in expression of hepatobiliary transporters across human, dog, monkey, and rat as determined by quantitative proteomics. Drug Metab Dispos. 43(3):367–374.
   PubMed Web of Science ®Google Scholar
• Wilson ZE, Rostami-Hodjegan A, Burn JL, Tooley A, Boyle J, Ellis SW, Tucker GT. 2003. Inter-individual variability in levels of human microsomal protein and hepatocellularity per gram of liver. Br J Clin Pharmacol. 56(4):433–440. Erratum in: Br J Clin Pharmacol 2004 58:680.
   PubMed Web of Science ®Google Scholar
• Windass AS, Lowes S, Wang Y, Brown CD. 2007. The contribution of organic anion transporters OAT1 and OAT3 to the renal uptake of rosuvastatin. J Pharmacol Exp Ther. 322(3):1221–1227.
   PubMed Web of Science ®Google Scholar